Results 21 to 30 of about 21,592 (229)

Impact of generic alendronate cost on the cost-effectiveness of osteoporosis screening and treatment. [PDF]

open access: yesPLoS ONE, 2012
Since alendronate became available in generic form in the Unites States in 2008, its price has been decreasing. The objective of this study was to investigate the impact of alendronate cost on the cost-effectiveness of osteoporosis screening and ...
Smita Nayak   +2 more
doaj   +1 more source

Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response

open access: yesFrontiers in Bioengineering and Biotechnology, 2022
Alendronate is the most widely used drug for postmenopausal osteoporosis (PMO). It inhibits bone resorption, affecting osteoclasts. Pharmacokinetics (PK) and pharmacodynamics (PD) of alendronate have been widely studied, but few mathematical models exist
José L. Calvo-Gallego   +3 more
doaj   +1 more source

Supra and subgingival application of antiseptics or antibiotics during periodontal therapy

open access: yesPeriodontology 2000, EarlyView., 2023
Abstract Periodontal diseases (gingivitis and periodontitis) are characterized by inflammatory processes which arise as a result of disruption of the balance in the oral ecosystem. According to the current S3 level clinical practice guidelines, therapy of patients with periodontitis involves a stepwise approach that includes the control of the patient ...
Elena Figuero   +5 more
wiley   +1 more source

Improvement of osteoblast adhesion, viability, and mineralization by restoring the cell cytoskeleton after bisphosphonate discontinuation in vitro [PDF]

open access: yesJournal of Applied Oral Science
Bisphosphonates are prescribed to treat excessive bone resorption in patients with osteoporosis. However, its use is associated with potential adverse effects such as medication-related osteonecrosis of the jaw, prompting the introduction of the drug ...
Somying PATNTIRAPONG   +3 more
doaj   +1 more source

Alendronate Prevents Early Periprosthetic Bone Loss in Cementless Total Hip Arthroplasty Better Than Simvastatin

open access: yesApplied Sciences, 2022
Background and Objectives: Cementless total hip arthroplasty leads to an early periprosthetic bone loss, which can impair the osseointegration process and lead to a femoral implant migration during early weight-bearing.
Dragos Apostu   +7 more
doaj   +1 more source

Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend

open access: yesBone Reports, 2019
Abaloparatide is a selective activator of the parathyroid hormone type 1 receptor signaling pathway that favors the stimulation of bone formation. Here, we report a prospective, exploratory analysis of bone mineral density (BMD) response rates comparing ...
Chad L. Deal   +4 more
doaj   +1 more source

Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis

open access: yesBiomedicines, 2021
Osteoarthritis (OA) is the most common degenerative joint disease causing progressive damages of the cartilage and subchondral bone, synovial inflammation, and severe pain.
Lyudmila Belenska-Todorova   +7 more
doaj   +1 more source

Esophageal ulcer and alendronate [PDF]

open access: yesSao Paulo Medical Journal, 1998
OBJECTIVE: To describe a case of esophageal ulcer associated with the use of alendronate. CASE REPORT: This is the fifth case ever described in the literature according to our bibliographic review. In our patient, the association between the drug and the esophageal lesions was masked by the presence of a hiatal hernia, potentially a cause of the ...
Angelo Paulo Ferrari Junior   +1 more
openaire   +3 more sources

Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates

open access: yesJournal of Osteoporosis, 2014
The objective of this study was to compare the disintegration times among Canadian-marketed brand (alendronate 70 mg, alendronate 70 mg plus vitamin D 5600 IU, and risedronate 35 mg) and generic (Novo-alendronate 70 mg and Apo-alendronate 70 mg) once ...
Wojciech P. Olszynski   +2 more
doaj   +1 more source

Alendronate gastric ulcers [PDF]

open access: yesAlimentary Pharmacology & Therapeutics, 1999
Background: It appears likely that drugs other than NSAIDs may cause ulcers and ulcer complications (e.g. potassium chloride). Alendronate (Fosamax) is used in the treatment and prevention of metabolic bone disease and has also been associated with severe oesophageal damage and stricture.
D Y, Graham, H M, Malaty
openaire   +2 more sources

Home - About - Disclaimer - Privacy